PledPharma: PledPharma AB PledPharma presents results from study on drug candidate Aladote for paracetamol poisoning at a global toxicology conference

Stockholm December 13 2018. PledPharma AB publ announces that the company's Aladote Phase IbIIa study results has been accepted for a poster presentation during the "58th Annual Meeting of the...